Stefani Jones, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2602 Parkway, Ceres, CA 95307 Phone: 209-404-1420 |
Melissa Alcazar, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1904 Richland Ave, Ceres, CA 95307 Phone: 209-300-8800 |
Ms. Sanjeela Ram, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2028 Garland Ct, Ceres, CA 95307 Phone: 209-765-5659 |
Sunila Singh, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3941 Annigoni Ct, Ceres, CA 95307 Phone: 209-538-3619 |
Lynette Rene Hunter, LVN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1904 Richland Ave # B110, Ceres, CA 95307 Phone: 209-525-6146 |
Steven Paul Rodriguez, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1420 Cameron Park Ct, Ceres, CA 95307 Phone: 209-324-1188 |
News Archive
Medical Equipment Solutions and Applications, Europe's leader in multi-vendor service for Diagnostic Imaging systems, equipment and parts, and Heidelberg-based radiology management company Curagita are joining forces to bring new and broader solutions for a full range of Diagnostic Imaging services to the German healthcare market.
CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.
IONTAS Limited, a leader in the discovery and optimisation of fully human antibodies, today announced a collaborative paper published in Nature Communications with the Technical University of Denmark, and the Instituto Clodomiro Picado of the University of Costa Rica describing the development of a panel of human antibodies that neutralise elements of black mamba snake toxin in an in vivo model.
Different types of dementia show dissimilar changes in brain activity. A network mapping technique described in the open access journal BMC Neuroscience has been applied to EEG data obtained from patients with Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD, a less common type of dementia with more prominent behavioral symptoms).
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge. A novel nanoparticle-based approach that enables more efficient delivery of siRNA drugs is presented in Nucleic Acid Therapeutics, a peer-reviewed journal from Mary Ann Liebert, Inc. publishers.
› Verified 8 days ago